New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:04 EDTARNAArena Pharmaceuticals to receive $500K milestone paument from Eisai
Arena Pharmaceuticals will receive a milestone payment of $500K from Eisai Laboratorios Ltda., a subsidiary of Eisai Inc., related to the filing of a marketing authorization for Belviq as a treatment for chronic weight management with the Brazilian Health Surveillance Agency.
News For ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
09:39 EDTARNAActive equity options trading
Subscribe for More Information
08:06 EDTARNAArena Pharmaceuticals granted patent covering ralinepag
Arena Pharmaceuticals announced that the US Patent and Trademark Office granted Arena U.S. Patent No. 8,895,776, entitled "Modulators of the Prostacyclin Receptor Useful for the Treatment of Disorders Related Thereto," covering ralinepag, an orally available agonist of the prostacyclin, or IP, receptor. Ralinepag is an investigational drug candidate being developed by Arena for the treatment of vasospastic diseases such as pulmonary arterial hypertension.
November 18, 2014
07:37 EDTARNAStifel to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use